Puma Biotechnology Inc. PBYI
$7.03
▲ +1.38% 24H
About
Puma Biotechnology Inc. is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies aimed at treating cancer. Its primary focus centers on enhancing cancer treatment through advanced pharmaceutical interventions, particularly targeting breast cancer and other tumors that ov…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees179
TickerPBYI
Statistics
Market Cap$357.7M
Revenue (TTM)$228.4M
Net Income$31.1M
Net Margin13.6%
EPS$0.61
P/E15.06
P/S1.62
P/B2.86
EV/EBITDA6.89
ROE21.6%
Dividend Yield—
Price$7.03
Data: Twelve Data · Revenue = mcap / P/S